US 12226425
Inhibitors of ARG1 and/or ARG2
granted A61KA61K31/282A61K31/69
Quick answer
US patent 12226425 (Inhibitors of ARG1 and/or ARG2) held by Arcus Biosciences, Inc. expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arcus Biosciences, Inc.
- Grant date
- Tue Feb 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/282, A61K31/69, A61K31/704, A61K33/243